Stepan (SCL) Could Be 18% Below Fair Value After Strong Q3 Results And Dividend Hike
Analysts set a $85.0 price target for Stepan, expecting 2029 revenues of $2.8B, earnings of $305.5M, and a PE ratio of 8.1x with an 8.1% discount rate. The company reported strong Q3 results and raised its dividend.
How this was made

The 30-second read
Why it matters
The new consensus target could influence short‑term trading and analyst coverage.
Market read
Analyst target update provides modest new information for traders.
What to watch
Potential cost pressures and competitive dynamics not reflected in the target.
Background
Stepan is a specialty chemicals producer listed on NYSE under SCL.
Ticker impact
Analysts set a consensus price target of $85.0 for Stepan based on projected 2029 earnings and revenue.
likely upward pressure as the market prices in the higher target.
The target reflects optimistic long‑term earnings growth, which may attract buyers.
Market effects
May lift sentiment for specialty chemicals peers.
Limited to US specialty chemicals sector.
Minimal.
Counterpoint
Target may be overly optimistic given macro uncertainties.
Key entities
- CompanyStepan Company
US‑listed specialty chemicals manufacturer.



